Aop Hlth Drug Patent Portfolio

Aop Hlth owns 1 orange book drug protected by 1 US patent Given below is the list of Aop Hlth's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10722516 Use Of Landiolol Hydrochloride In The Long-Term Treatment Of Tachyarrhythmias 25 Apr, 2034
Active


Given below is the list of recent legal activities going on the following drug patents of Aop Hlth.

Activity Date Patent Number
Patent litigations
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 31 Oct, 2024 US10722516
Payment of Maintenance Fee, 4th Yr, Small Entity 11 Jan, 2024 US10722516
Patent Issue Date Used in PTA Calculation 28 Jul, 2020 US10722516
Recordation of Patent Grant Mailed 28 Jul, 2020 US10722516
Email Notification 09 Jul, 2020 US10722516
Issue Notification Mailed 08 Jul, 2020 US10722516
Application Is Considered Ready for Issue 25 Jun, 2020 US10722516
Dispatch to FDC 25 Jun, 2020 US10722516
Issue Fee Payment Verified 17 Jun, 2020 US10722516
Issue Fee Payment Received 17 Jun, 2020 US10722516
Electronic Review 31 Mar, 2020 US10722516
Email Notification 31 Mar, 2020 US10722516
Mail Notice of Allowance 31 Mar, 2020 US10722516
Notice of Allowance Data Verification Completed 26 Mar, 2020 US10722516
Information Disclosure Statement considered 25 Mar, 2020 US10722516


Aop Hlth's Family Patents


Family Patents



Aop Hlth Drug List

Given below is the complete list of Aop Hlth's drugs and the patents protecting them.


1. Rapiblyk

Rapiblyk is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10722516 Use Of Landiolol Hydrochloride In The Long-Term Treatment Of Tachyarrhythmias 25 Apr, 2034
(8 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rapiblyk's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List